Welcome of the Chair
H. Gisslinger
CHAIR & MODERATOR: H. Hasselbalch, R. Kralovics
CHIP
R. Skoda
Cardiovascular aspects
C. Binder
COFFEE BREAK & Speaker's corner
CHAIR & MODERATOR: A. Hatalová, V. Buxhofer-Ausch
What is available in 2023
H. Gisslinger
Future outlook
R. Kušec
Departure to dine-arounds
Opening
A. Álvarez-Larrán
CHAIR & MODERATOR: M. Egyed, H. Gisslinger
Low risk vs. high risk
T. Barbui
Patient Case
V. Buxhofer-Ausch
Splanchnic vein thrombosis
J. J. Kiladjian
Patient Case
A. Alvarez-Larrán
BREAK + Speaker's corner
Pregnancy
M. Griesshammer
Patient Case
W. Sin
Life long management
R. Silver
Patient Case
M. Krauth
LUNCH BREAK + Speaker'S corner
Secondary malignancies
F. Palandri
Patient case
A. Rovó
Overcoming treatment resistance
F. Heidel
Patient case
M. Doubek
BREAK & Speakers Corner
EVOLUTION IN MPN CARE – THE PATIENT PERSPECTIVE
CHAIR & MODERATOR: F. Palandri, M. Sobas
What has changed?
H. K. Al-Ali
QoL
R. Mesa
Departure to dinner, meeting point lobby of Hotel NH Málaga
SELECTED TOPICS IN MYELOID MALIGNANCIES
CHAIR & MODERATOR: F. Passamonti, A. Rovó
"Hot Topic: mutant CALR as a unique drug target in MPN“
R. Kralovics
MF
F. Passamonti
CML
P. Rousselot
AML
M. Wondergem
Eosinophil malignancies
A. Reiter
Farewell on behalf of CEMPO
H. Gisslinger
